Beste Pharma Market Access Podcasts (2024)

1
NHS primary care panel – the GP Contract and Operational Planning Guidance 1:02:14

29d ago1:02:14

1:02:14

What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–25? In this webinar, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) spoke to a…

1
E134 | The Role of AI in Disrupting Traditional Healthcare 24:34

9h ago24:34

24:34

In this episode of AI for Pharma Growth, Dr. Andree Bates sits down with Cav. Franco Lofranco, CEO of APM Global, to explore how artificial intelligence is revolutionising the healthcare industry, making it more affordable and accessible. They discuss the challenges of the current healthcare system in the United States, including high costs and ine…

1
Circulating Tumor DNA: Transforming Oncology Clinical Trials 20:01

7d ago20:01

20:01

Use of circulating tumor DNA (ctDNA) – small fragments of DNA that are released into the bloodstream by cancer cells – as a diagnostic tool represents a significant shift toward more precise, personalized cancer care, enhancing both trial efficiency and patient experience. Unlike traditional tissue biopsies, which sample a single tumor site, ctDNA …

1
156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar 33:01

7d ago33:01

33:01

On this episode, I was joined by Laxman Halleppanavar, Head of Portfolio Strategy and Management at Credence MedSystems, Inc. On this episode, Laxman, highlights the differences in regulatory oversight and risk management between medical devices and pharmaceuticals, the trend towards home administration of drugs, sustainability goals, and the chall…

1
Medication Adherence for Patients with Severe Mental Illness. 3:53

7d ago3:53

3:53

Send us a text Medication Adherence for Patients with Severe Mental Illness. Adherence to prescribed medication regimens improves outcomes for patients with severe mental illness, such as schizophrenia, bipolar disorders, and major depressive disorder. Psychiatric disorders are a significant public health problem: schizophrenia affects about 23 mil…

1
E133 | How to Ensure a Stronger Supply Chain Leveraging AI 33:31

7d ago33:31

33:31

In this episode, host Dr. Andree Bates sits down with Raj Bhattacharya, who previously headed the go-to-market function for pharma and life sciences at One Network. Raj shares his extensive background in the pharmaceutical industry, having worked in production, formulations R&D, and supply chain roles for companies like AstraZeneca and Allergan. Ra…

1
155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach 25:25

14d ago25:25

25:25

On this episode, I was joined by Laurie Auerbach, President and Principal Consultant, Compliance Prodigies, LLC. In this episode, Laurie dives into the complexities of FDA compliance programs, specifically focusing on combination product inspections and the 7356.000 Inspections of CDER-led or CDRH-led Combination Products compliance program. Laurie…

1
E132 | Leveraging AI to Protect Human Vocal Authenticity 25:49

14d ago25:49

25:49

This episode of AI for Pharma Growth features an interview with Noah Kjos, the Co-Founder and COO of DeepTrust, a company that offers an AI tool to authenticate whether an audio recording was generated by an AI voice or a human voice. Andree and Noah discuss the growing threat of deep fake audio scams and the importance of being able to verify the …

1
Cashing in on the Currency of Information 34:22

15d ago34:22

34:22

Medical science liaisons—or MSLs—within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders. And only they can bring back medical insights to guide strategic development and brand decisions. Yet, can…

1
Repairing Fragmented Care with Value-Based Strategies with Dr. Kamal Golla 46:51

19d ago46:51

46:51

🎙 ABOUT DR VISHNUKAMAL GOLLA Dr. Vishnukamal Golla is the medical director for value transformation at Evolent, a specialty and primary care management company. In this role, Dr. Golla leads the implementation of innovative value-based care models in specialty care. In helping Evolent manage approximately $1 billion of risk-based oncology and cardi…

1
154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell 37:31

21d ago37:31

37:31

On this episode, I was joined by Devon Campbell, Founder and Managing Director of Prodct. Devon covers the differences between IVDs, companion diagnostics, and precision medicine, the risk management aspects specific to IVDs, and the design, verification, and validation processes involved. Devin shares his extensive experience in both big pharma en…

1
E131 | Leveraging A Robotic Pill for Non-Invasive Access to the Body 30:35

21d ago30:35

30:35

This episode of AI for Pharma Growth features an interview with Torrey Smith, the Co-Founder and CEO of Endiatx, a company developing a revolutionary robotic pill that can provide a non-invasive way to observe inside the human body. Torrey explains the journey of Endiatx, progressing from a startup in a Silicon Valley garage to clinical trials and …

1
CRISPR Gene-Editing Therapy 3:35

22d ago3:35

3:35

Send us a text Introduction to Gene-Editing Therapy: CRISPR CRISPR is a relatively new medical advancement that was inspired by the natural defense mechanism found in some microbes, such as bacteria. To protect themselves against invaders like viruses, these microbes capture snippets of the intruder’s DNA and store them away as segments called CRIS…

1
153 - USP 382, Elastomeric Component Functional Suitability, Delivery Systems, Spikes, IV Bags and Alternate Packaging with Fran Degrazio 21:56

28d ago21:56

21:56

On this episode, I was joined by Fran Degrazio, President & Principal Consultant at Strategic Parenteral Solutions and Executive Editor at Drug Delivery Leader. On this episode, Fran explores the transition from USP 381 to 382, focusing on stoppers and elastomeric closures. Fran explains the importance of evaluating packaging components as a system…

1
E130 | Leveraging AI in Neuromarketing 25:35

28d ago25:35

25:35

This episode features an interview with Marco Baldocchi, the founder and CEO of the Marco Baldocchi Group, who specialises in leveraging AI in neuromarketing. Marco discusses his background in marketing and economics, and how a personal experience with buying a car led him to explore the unconscious decision-making processes of consumers. Marco exp…

1
152 - Global Medical Device Podcast Interview: Behind the Combinate Podcast, Combination Products Why, Unique Episodes, Pyramids and Books with Etienne Nichols & Subhi Saadeh 40:48

1M ago40:48

40:48

This episode is a cross-post of an interview I did with Etienne Nichols over at the Global Medical Device Podcast at GreenLight Guru(Episode #380). In this episode, Etienne and I discuss: 02:50 The Start of the Combinate Podcast 06:00 Efficiency and Tools in Podcast Production 08:40 Understanding Combination Products 09:43 Regulatory Frameworks and…

1
E129 | Leveraging Wastewater and AI to Predict Population Health Threats 22:23

1M ago22:23

22:23

In this episode, Dr. Andree Bates speaks to Mariana Matus, the co-founder and CEO of Biobot, a company that is transforming wastewater infrastructure into public health observatories. Mariana explains the concept of wastewater epidemiology, where wastewater samples from communities are collected and analysed for various disease indicators, includin…

1
Introduction to Targeted Therapies: CAR T-cell Therapy 3:30

1M ago3:30

3:30

Send us a text Introduction to Targeted Therapies: CAR T-cell Therapy T-cell Transfer Therapy is a special type of immunotherapy that takes a person’s own T-cells (a type of immune cell), adds specific antigens to the T-cells that can identify the cancer cells, and puts them back into the person’s body. Cancer cells express unique antigens (signali…

1
151 - Primary Packaging/Container Closure Change Guidance, Post-Approval Changes, Sponsor/Supplier Relationships, Purchasing Controls and Tubular vs. Molded Glass with Fran Degrazio 33:38

1M ago33:38

33:38

On this episode, I was joined by Fran Degrazio, President & Principal Consultant at Strategic Parenteral Solutions and Executive Editor at Drug Delivery Leader. On this episode, Fran discusses: 00:00 Introduction 02:29 Understanding the FDA's New Guidance: 05:05 Challenges in Supplier Management and the 08:22 Navigating Change Management 11:43 Insi…

1
E128 | Leveraging AI for Early Disease Prediction 32:11

1M ago32:11

32:11

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Xander Kerman Gregory, the Head of Growth at Ubie Health, to discuss the company's innovative work in early disease prediction through the power of artificial intelligence. Ubie Health focussed on user-centric design to dynamically guide patients through a series of carefully se…

1
UBS’ Amir Vardi on Rate Cuts, CLO Outlook, and Market Volatility 43:16

1M ago43:16

43:16

This week on The Reorg Primary View, Amir Vardi, managing director and head of structured credit for the credit investments group at UBS Asset Management (formerly Credit Suisse Asset Management) joins Reorg’s Hugh Minch to discuss the outlook for the CLO market in the face of a more challenging macroeconomic environment.Vardi discusses the impact …

1
Decoding Gen AI’s Potential to Drive More Effective Clinical Trials 31:32

2M ago31:32

31:32

AI is seemingly everywhere now in our lives, including healthcare and drug discovery and development. AI certainly has the potential to enable major advances than development of more effective and safe medical products. And in fact, GenAI has already been successfully used in drug discovery. But are we fully leveraging the current AI yet in practic…

1
150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar 38:58

2M ago38:58

38:58

On this episode, I was joined by Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb. On this episode, Maysaa discusses:00:00 Welcome to Episode 150!03:00 Challenges and Innovations in Ocular Drug Delivery09:30 Understanding Intravitreal Injections13:26 Regulatory Considerations for Ocular Products20:48 Innovations in Glaucoma Treatment29:1…

1
E127 | Who is using your face? Find out with AI 26:56

2M ago26:56

26:56

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …

1
Provider Insights on the Impact of 340B Pricing 3:54

2M ago3:54

3:54

Send us a text Provider Insights on the Impact of 340B Pricing. We frequently get asked for insights on how the 340B Drug Pricing Program may... or may not... be impacting the prescribing choices of participating covered entities. The Health Resources and Services Administration (HRSA) administers this federal program which is intended to help safe…

1
Jim Schaeffer on Market Volatility, Dividends & Liability Management 37:53

2M ago37:53

37:53

This week on The Reorg Primary View, Reorg's Katherine Schwartz speaks to Jim Schaeffer of Aegon Asset Management, where Jim is the global head of leveraged finance and serves as a portfolio manager for the various leveraged finance strategies. They discuss the recent volatility in markets, how anticipated rate changes might affect the market and M…

1
Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri 1:00:35

2M ago1:00:35

1:00:35

🎙ABOUT DR. ROBERT HARIRI: Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he s…

1
149 - Lyophilization/Freeze-Drying Equipment, Environment, Cleaning, Loading, Automation, Refrigeration, Vacuum, Filtration, and Potent/Non-Aqueous Considerations with David Simoens 33:11

2M ago33:11

33:11

On this episode, I was joined by David Simeons, Founder of Life Science Professionals and an expert in Lyophilization/Freeze-Drying. On this episode David discusses:01:01 Recap of the Last Episode01:23 Understanding the Freeze Drying Environment01:46 Freeze Drying Equipment and Processes03:01 Cleaning and Validation in Freeze Drying03:58 Loading an…

1
E126 | The impact of RAG and LLMs on data processing and decision-making 25:51

2M ago25:51

25:51

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to veri…

1
Insights into European Direct Lending with Patrick Ottersbach 22:19

2M ago22:19

22:19

Join Oscar Laurikka, Deputy Head of Private Credit and Deal Origination at Reorg, as he sits down with Patrick Ottersbach, Head of Macquarie Capital Private Credit in Europe, to delve into the intricacies of European direct lending. In this episode, Patrick talks about the history and evolution of direct lending at Macquarie, the importance of a fl…

1
Mohammed Murad of PT Asset Management: H1’24 High-Yield Munis, Deal Criteria, H2’24 Opportunities 32:03

2M ago32:03

32:03

This week on The Reorg Primary View, Reorg's Hoa Nguyen speaks with Mohammed Murad, director of municipal credit research at PT Asset Management about high-yield muni performance in the first half of 2024 and what to expect in the upcoming months. Hoa and Mohammed also discuss criteria for an attractive healthcare or industrial development deal and…

1
Engage NHS healthcare decision-makers with RWD 20:55

2M ago20:55

20:55

Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted par…

1
Driving Better Outcomes with Ambulatory Surgical Centers 54:26

2M ago54:26

54:26

ABOUT ARIC BURKE Aric brings over eighteen years of experience in ASC consulting, development, and operations. He oversees the strategic vision, operational management, and organizational structure of Atlas, driving its profitability and strategic direction. Before founding Atlas, Aric was the West Market President for United Surgical Partners Inte…

1
148 - Standards Applicability Assessments, Atomic Requirements, Documentation and Timing with Leo Eisner 26:20

2M ago26:20

26:20

On this episode, I was joined by Leo Eisner "IEC 60601 Guy", Founder of Eisner Safety Consultants. On this episode, Leo discusses the complexities involved in assessing the applicability of standards to medical devices and combination products. Leo delves into the importance of understanding product environment, intended use, and market specifics. …

1
E125 | Using AI to power early detection and provide better treatments in oncology and cardiovascular care 23:20

2M ago23:20

23:20

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial cal…

1
The Federal NOPAIN Act 3:19

2M ago3:19

3:19

Send us a text Today’s topic is the The Federal NOPAIN Act. The Federal “Non-Opioids Prevent Addiction In the Nation Act” (or, the “NOPAIN Act”), Senate bill S.586, was signed into law in December 2022. It takes effect this coming January as part of the Centers for Medicare and Medicaid Services 2025 OPPS proposed rule. The NOPAIN Act directs CMS t…

1
SunPower's Chapter 11 Rumors, MultiPlan's Strategic Moves, and Steward Health's Hospital Closures 9:04

2M ago9:04

9:04

This week SunPower Corp. is preparing to file chapter 11 to pursue in-court asset sales, Steward Health plans to close two Massachusetts hospitals in the absence of viable bids, MultiPlan is working with Guggenheim Securities to explore balance sheet options because of mounting legal battles, and other interesting developments in the restructuring …

1
E124 | How AI is being used to tackle global health challenges 29:58

2M ago29:58

29:58

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…

1
147 - URRA Draft Guidance, uFMEA's, Design Validation, HF Summative, Comparative Analysis, Threshold Analysis and Compelling Technical Arguments with David Grosse-Wentrup 23:15

2M ago23:15

23:15

On this episode, I was joined by David Grosse-Wentrup, Research Director for Human Factors at Design Science Group. David walks through: David Grosse-Wentrup PhD is a Research Director at Design Science, a global human factors consultancy focused on advancing healthcare technology through user research and design evaluation. After his studies in bi…

1
Javier Garibay Discusses Navigating Unique Challenges of M&A and Commercial Bankruptcy in Mexico 35:02

2M ago35:02

35:02

This week on The Reorg Primary View, Javier Garibay, a senior associate at Mayer Brown in Mexico City specializing in M&A and restructuring, talks with Reorg's Maria Abreu about the challenges in restructuring Mexican companies that have issued bonds governed by U.S. law and are navigating commercial bankruptcy in Mexico, as well as strategies for …

1
146 - Lyophilization/Freeze-Drying, Filling, Sublimation, Disorption, Backfilling, Stoppers, Vacuum and Water's Triple Point with David Simoens 35:58

3M ago35:58

35:58

On this episode, I was joined by David Simoens, Founder of Life Science Professionals Inc. David walks through the freeze drying(lyo) process, primary drying via sublimation, secondary drying through desorption, and final steps such as backfilling and stoppering. David also explores the different considerations for lyophilization, the impact of var…

1
E123 | How AI is driving improved clinical, patient, and economic outcomes 27:26

3M ago27:26

27:26

In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibl…

1
High Value Pharmacy Enterprise Framework 4:23

3M ago4:23

4:23

Send us a text The High-Value Pharmacy Enterprise Framework. The High-Value Pharmacy Enterprise Framework is a collection of evidence-based and expert recommended best practices designed to enhance health system pharmacy operations by ensuring safe, effective, and patient-centered medication management throughout the health-system pharmacy enterpri…

1
Navigating Credit Market Storms: Alex Belgrade on Covid, LIBOR, and Altice 26:11

3M ago26:11

26:11

This week on The Reorg Primary View, Alex Belgrade, managing partner at Valitana, joins Reorg’s Hugh Minch to discuss how CLO managers and tranche investors have reacted to periods of volatility in the credit markets. Belgrade discusses strategies that involve a combination of information asymmetry and quick reaction time, with particular focus on …

1
145 - Regulatory Policy, Advocacy, Legislation, Combination Product Regulatory Harmonization, IMDRF and Ikigai with Ryan Hoshi 40:28

3M ago40:28

40:28

On this episode, I was joined by Ryan Hoshi, Director of Regulatory Policy and Intelligence at AbbVie. Ryan discusses: 01:18 Understanding Regulatory Policy 03:18 Ryan's Career Journey 05:08 Challenges in Regulatory Harmonization 06:54 Legislative Frameworks and Regulatory Differences Globally 11:10 FDA's Role and Recent Legislation (User Fee reaut…

1
E122 | Encouraging AI Adoption in Teams 29:06

3M ago29:06

29:06

In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable…

1
Insights into European Direct Lending with Mike Dennis 22:01

3M ago22:01

22:01

Join us for an exclusive interview with Mike Dennis, the co-head of European Credit at Ares, which manages nearly €70 billion in assets. In this episode, Mike shares his insights on the current state of the direct lending market, the impact of syndicated loans, fundraising challenges, and emerging trends in private credit. Listen to gain valuable p…

1
Introduction to Targeted Therapies: Monoclonal Antibodies 3:32

3M ago3:32

3:32

Send us a text Introduction to Targeted Therapies: Monoclonal Antibodies Targeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread. Antibodies are produced naturally by our body and help the immune system recognize cel…

1
Insights with Jeremy Burton of PineBridge Investments 31:27

3M ago31:27

31:27

This week on The Reorg Primary View, host Katherine Schwartz sits down with Jeremy Burton, a portfolio manager on the leveraged finance team at PineBridge. Together, they delve into the current mood of the high-yield and leveraged loan markets this summer. Key topics include the impact of the upcoming election on new-money issuance, the rise of lia…

1
144 - Auto-Injectors, Pen Injectors, Challenges in Product Development, Sponsors and CDMO's with David DeSalvo 35:36

3M ago35:36

35:36

On this episode, I was joined by David DeSalvo, Vice-President of Combination Product Development at Kindeva Drug Delivery. David and I discuss: 00:00 Introduction and Guest Overview00:04 David DeSalvo's Career Journey02:13 Understanding Injection Systems04:22 Early Career at BD10:51 Transition to SHL17:50 Starting a New Venture24:54 Experience at …

Podcasts, die es wert sind, gehört zu werden

Pharma Market Access Podcasts

Podcasts, die es wert sind, gehört zu werden

Kurzanleitung